Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 14101-04-3
2. Chembl496999
3. 8cik094kbu
4. Chebi:5168
5. C10349
6. 3-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-1,8-dihydroxy-6-methylanthracene-9,10-dione
7. 6-o-(d-apiofuranosyl)-1,6,8-trihydroxy-3-methylanthraquinone
8. Ac1l9dbz
9. Unii-8cik094kbu
10. Einecs 237-953-9
11. Frangulinb
12. Frangulin B [mi]
13. Surecn1426453
14. Schembl1426453
15. Frangulin B, Analytical Standard
16. Dtxsid80930972
17. Chebi:601858
18. Zinc4098675
19. 3-(d-apio-beta-d-furanosyloxy)-1,8-dihydroxy-6-methylanthraquinone
20. Bdbm50269014
21. Mfcd00016362
22. Akos015914181
23. A807715
24. Q27106674
25. 9,10-anthracenedione,3-(d-apio-b-d-furanosyloxy)-1,8-dihydroxy-6-methyl-
26. 9,10-anthracenedione, 3-(d-apio-.beta.-d-furanosyloxy)-1,8-dihydroxy-6-methyl-
27. 3-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-1,8-dihydroxy-6-methyl-anthracene-9,10-dione
28. 3-[(2s,3r,4r)-4-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]oxy-6-methyl-1,8-bis(oxidanyl)anthracene-9,10-dione
29. 3-[[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)-2-oxolanyl]oxy]-1,8-dihydroxy-6-methylanthracene-9,10-dione
30. 3-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-1,8-dihydroxy-6-methylanthracene-9,10-dione
| Molecular Weight | 402.4 g/mol |
|---|---|
| Molecular Formula | C20H18O9 |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 402.09508215 g/mol |
| Monoisotopic Mass | 402.09508215 g/mol |
| Topological Polar Surface Area | 154 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 668 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
66
PharmaCompass offers a list of Frangulin B API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Frangulin B manufacturer or Frangulin B supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Frangulin B manufacturer or Frangulin B supplier.
PharmaCompass also assists you with knowing the Frangulin B API Price utilized in the formulation of products. Frangulin B API Price is not always fixed or binding as the Frangulin B Price is obtained through a variety of data sources. The Frangulin B Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Frangulin B manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Frangulin B, including repackagers and relabelers. The FDA regulates Frangulin B manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Frangulin B API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Frangulin B supplier is an individual or a company that provides Frangulin B active pharmaceutical ingredient (API) or Frangulin B finished formulations upon request. The Frangulin B suppliers may include Frangulin B API manufacturers, exporters, distributors and traders.
Frangulin B Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Frangulin B GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Frangulin B GMP manufacturer or Frangulin B GMP API supplier for your needs.
A Frangulin B CoA (Certificate of Analysis) is a formal document that attests to Frangulin B's compliance with Frangulin B specifications and serves as a tool for batch-level quality control.
Frangulin B CoA mostly includes findings from lab analyses of a specific batch. For each Frangulin B CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Frangulin B may be tested according to a variety of international standards, such as European Pharmacopoeia (Frangulin B EP), Frangulin B JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Frangulin B USP).
